13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001600004
Total reported value
$1.6B
$1.6B
50 檔
19.7%
According to the latest 13F quarterly dataset, First Light Asset Management, LLC managed an equity portfolio of $1.6B at the end of Q1 2024, spanning 50 distinct U.S. exchange-listed positions.
During Q1 2024, First Light Asset Management, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 6.06% | -0.45% | -14.97% | |
| 2 | ATEC | Alphatec Holdings Inc | Stock-Other | 5.72% | — | -9.34% | |
| 3 | NTRA | Natera Inc | Stock-Healthcare | 4.60% | — | +295.88% | |
| 4 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 4.35% | — | -19.77% | |
| 5 | PLRX | Pliant Therapeutics Inc | Stock-Other | 4.03% | — | -1.58% | |
| 6 | TMDX | Transmedics Group Inc | Stock-Healthcare | 4.03% | — | -5.65% | |
| 7 | SWAVUSD | Shockwave Medical Inc | Stock-Other | 4.03% | — | +34.99% | |
| 8 | NEO | Neogenomics Inc | Stock-Healthcare | 3.97% | +4.42% | -15.91% | |
| 9 | IRTC | Irhythm Holdings Inc | Stock-Healthcare | 3.74% | -0.57% | +176.79% | |
| 10 | FNAUSD | Paragon 28 Inc | Stock-Other | 3.60% | — | -0.39% | |
| 11 | TCMD | Tactile Systems Technology I | Stock-Other | 3.29% | +0.84% | NEW | |
| 12 | ATRC | Atricure Inc | Stock-Other | 3.22% | -0.90% | +2.48% | |
| 13 | SIBN | Si-bone Inc | Stock-Other | 3.10% | +2.00% | -2.91% | |
| 14 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 2.83% | — | +6.15% | |
| 15 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 2.60% | -5.56% | EXIT | |
| 16 | RCM1USD | R1 Rcm Inc | Stock-Other | 2.52% | — | +212.79% | |
| 17 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 2.39% | — | +117.29% | |
| 18 | PFMTUSD | Performant Financial CORP | Stock-Other | 2.37% | — | +8.74% | |
| 19 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 2.30% | — | +58.10% | |
| 20 | BCYC | Bicycle Therapeutics Plc-adr | Stock-Other | 2.27% | — | -23.05% | |
| 21 | STVN | Stevanato Group S.p.A. | Stock-Other | 2.05% | — | +14.52% | |
| 22 | PODD | Insulet CORP | Stock-Healthcare | 1.99% | — | — | |
| 23 | MODNEUR | Model N Inc | Stock-Other | 1.95% | — | -41.96% | |
| 24 | AVTR | Avantor Inc | Stock-Healthcare | 1.67% | — | +5728.27% | |
| 25 | PRVA | Privia Health Group Inc | Stock-Other | 1.66% | — | — | |
| 26 | ANAB | Anaptysbio Inc | Stock-Other | 1.63% | -0.42% | -23.69% | |
| 27 | RAH | Societal Cdmo Inc | Stock-Other | 1.63% | — | — | |
| 28 | OPRX | Optimizerx CORP | Stock-Other | 1.62% | — | +0.60% | |
| 29 | NVLSEUR | Alpine Immune Sciences Inc | Stock-Other | 1.52% | — | — | |
| 30 | VERA | Vera Therapeutics Inc | Stock-Other | 1.44% | -1.13% | EXIT | |
| 31 | TNDM | Tandem Diabetes Care Inc | Stock-Other | 1.29% | +0.84% | +31.88% | |
| 32 | TELA | Tela Bio Inc | Stock-Other | 1.20% | — | +7.80% | |
| 33 | IDYA | Ideaya Biosciences Inc | Stock-Other | 1.13% | — | -2.95% | |
| 34 | KRMD | Koru Medical Systems Inc | Stock-Other | 0.94% | -0.60% | +1.11% | |
| 35 | PRTA | Prothena Corporation plc | Stock-Other | 0.84% | — | -59.13% | |
| 36 | NARIUSD | Inari Medical Inc | Stock-Other | 0.79% | — | — | |
| 37 | EVH | Evolent Health Inc - A | Stock-Other | 0.72% | — | +252.64% | |
| 38 | PEN | Penumbra Inc | Stock-Healthcare | 0.65% | — | — | |
| 39 | THC | Tenet Healthcare CORP | Stock-Healthcare | 0.64% | — | -59.14% | |
| 40 | INSM | Insmed Inc | Stock-Healthcare | 0.59% | — | -56.23% | |
| 41 | GPCR | Structure Therapeutics Inc | Stock-Other | 0.49% | — | — | |
| 42 | AXGN | Axogen Inc | Stock-Other | 0.47% | -4.16% | +177.00% | |
| 43 | LIVN | LivaNova PLC | Stock-Other | 0.44% | — | — | |
| 44 | HCAT | Health Catalyst Inc | Stock-Other | 0.42% | +0.08% | -27.58% | |
| 45 | PCVX | Vaxcyte Inc | Stock-Other | 0.32% | +0.48% | — | |
| 46 | GH | Guardant Health Inc | Stock-Healthcare | 0.30% | +1.71% | +31.74% | |
| 47 | VTYXUSD | Ventyx Biosciences Inc | Stock-Other | 0.26% | — | — | |
| 48 | DYN | Dyne Therapeutics Inc | Stock-Other | 0.23% | — | — | |
| 49 | SLP | Simulations Plus Inc | Stock-Other | 0.09% | +0.32% | -16.57% | |
| 50 | ✓ | Stock-Other | 0.04% | — | — |
According to official SEC Form 13F filings, First Light Asset Management, LLC reported a total U.S. public equity portfolio value of $1.6B across 50 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including CRNX, ATEC, NTRA) accounted for 19.7% of total reported equity market value during Q1 2024.
During Q1 2024, First Light Asset Management, LLC's top holdings by market value included CRNX (6.1%)、ATEC (5.7%)、NTRA (4.6%). The largest single position, CRNX, represented 6.1% of total portfolio value.
In Q1 2024, First Light Asset Management, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.